AddLife AB (publ) (ALIF-B.ST) Stock Analysis & Winston Score
AddLife AB is a Swedish healthcare company that distributes medical and laboratory equipment across Europe. It sells products like diagnostic tools, surgical instruments, and lab supplies to hospitals, clinics, and research laboratories. The company does not manufacture most of its products — instead, it acts as a middleman between global medical device makers and healthcare customers. AddLife makes money by buying products from manufacturers and reselling them at a markup, earning a roughly 38% gross margin. It operates mainly in the Nordic countries and broader Europe, with over 100 subsidiary companies acquired over the years through an active acquisition strategy. Its competitive edge comes from deep local market relationships and a decentralized business model that lets each subsidiary operate independently. The main risk is that its growth depends heavily on finding and integrating new acquisitions at reasonable prices — if deal flow slows or integration stumbles, growth could stall.
Winston Score: 49/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (9/30)
- Growth: Strong (15/20)
- Cash Flow: Strong (8/10)
- Stability: Good (6/10)
- Valuation: Mixed (4/10)
- Ownership: Mixed (6/15)
Key Facts
Price: $160.80
Market Cap: $18.9B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: Stockholm Stock Exchange



